Skip to main content
logo
Glenmark Pharmaceuticals Limited (BOM:532296)
India flag India · Delayed Price · Currency is INR
2,189.55
-24.50 (-1.11%)
At close: Jun 22, 2026

Glenmark Pharmaceuticals Revenue

In the fiscal year ending March 31, 2026, Glenmark Pharmaceuticals had annual revenue of 169.83B INR with 27.08% growth. Glenmark Pharmaceuticals had revenue of 37.71B in the quarter ending March 31, 2026, with 14.34% growth.

Revenue
169.83B
Revenue Growth
+27.08%
P/S Ratio
3.64
Revenue / Employee
10.75M
Employees
15,800
Market Cap
618.56B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026169.83B36.19B27.08%
Mar 31, 2025133.63B7.18B5.68%
Mar 31, 2024126.45B9.90B8.49%
Mar 31, 2023116.56B-6.49B-5.28%
Mar 31, 2022123.05B13.61B12.44%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Dr. Reddy's Laboratories335.93B
Lupin279.58B
Torrent Pharmaceuticals139.80B
Jubilant Pharmova82.80B
Abbott India69.29B
Granules India53.66B
J. B. Chemicals & Pharmaceuticals41.48B
GlaxoSmithKline Pharmaceuticals38.22B
Revenue Rankings

Glenmark Pharmaceuticals News

More News